Medrx Reports Monthly Exercise Status of Third-Party Allotment Warrant Issue

TOKYO, Jul 01 (Pulse News Wire) – Medrx CO.,LTD. (4586.T) reported the monthly exercise status of its 35th issue of warrants (with adjusted exercise price clause) allotted to Growth Capital Corporation in June 2026.

A total of 9,060 warrants were exercised during the month, representing a ratio of 6.13% against the total issuance of 147,820 warrants. As of June 5, 2026, there were 147,820 unexercised warrants remaining, accounting for 14,782,000 of the total issuance. The detailed exercise activity for June included several transactions, such as exercising 56 warrants on June 8 and June 10, and 51 warrants on June 15, 17, and 18.

On June 22, 71,800 shares were delivered upon warrant exercise at an exercise price of ¥1,490 per share. By the end of June, the number of unexercised warrants stood at 138,760, which represents 13,876,000 of the total issuance. Regarding the exercise restrictions based on Article 434 of the listing regulations, the combined outstanding share count was 906,000, while the listed share count at the time of issuance was 59,365,100.

The exercise ratio subject to restriction was calculated as 1.53%.